Accelerated Clinical Trial Agreement (ACTA) Update
The Accelerated Clinical Trial Agreement (ACTA) was prepared with the intent to facilitate relationships with industry sponsors that are interested in expediting the contract process, thus optimizing lag time for research.
On June 28, 2019, the ACTA Working Group held an in-person meeting to review the most recent draft. A summary of the meeting can be found below. For more information on ACTA, click here.
UIDP obtains consent to electronically disseminate presentations and other organization's publications. The consent obtained by UIDP is not transferable. For clarifications about the consent provided or to obtain additional information about this document, email email@example.com.